NLRP3 MODULATORS
The present invention provides compounds of Formula (I): wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
14.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | The present invention provides compounds of Formula (I): wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human). |
---|---|
Bibliography: | Application Number: US201917267516 |